TLR3 and head and neck cancer: Inhibition of NF-κB in head and neck cancer cell lines was associated with downregulation of TLR3 and decreased levels of IL-6 and IL-8 and the expected shift to a TH2 microenvironment, typical in head and neck squamous cell carcinomas did not occur (33).